| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/09/2009 | EP2097140A2 Polymer encapsulation and/or binding |
| 09/09/2009 | EP2096927A2 Therapeutic compositions and methods of treatment with capsianoside-type compounds |
| 09/09/2009 | EP1532109B1 Pyrrolidine derivatives as oxytocin antagonists |
| 09/09/2009 | EP1509621B1 Diagnostic of alzheimer's disease by analysis of il-10 gene polymorphisms |
| 09/09/2009 | EP1458447B1 Combination of cytochome p 450 dependent protease inhibitors |
| 09/09/2009 | EP1392326B1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 09/09/2009 | EP1379243B1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 09/09/2009 | EP1290027B1 Immunoadhesin for the prevention of rhinovirus infection |
| 09/09/2009 | EP0999835B1 Imidazole derivatives as mdr modulators |
| 09/09/2009 | CN101525373A Inhibitor of TGF-beta activation reaction |
| 09/09/2009 | CN101524532A Single dose of a mycoplasma hyopneumoniae vaccine |
| 09/09/2009 | CN101524530A The treatment of diabetes |
| 09/09/2009 | CN101524493A Multifunctional Chinese medicine honeyed pill |
| 09/09/2009 | CN101524389A Use of Brassica rapa polysaccharide in preparation of anti-hypoxia drugs |
| 09/09/2009 | CN101524378A Anti-ageing traditional Chinese medicine preparation |
| 09/09/2009 | CN101524362A Application of nucleic acid with CpG motif for preparing anti-fibrotic drug |
| 09/09/2009 | CN101524350A Application of N-methyl-N-benzyl-3-chloro-6-methoxyl-benzothiophene -2-formamide |
| 09/09/2009 | CN100537770C Von willebrand factor (vWF)-cleaving enzyme |
| 09/09/2009 | CN100537598C Substantially crystalline form of melagatran |
| 09/09/2009 | CN100537571C Imidazo[1,2-a]pyrazin-8-ylamines, method of making and method of use thereof |
| 09/09/2009 | CN100537546C Novel alkansulfonamides as endothelin antagonists |
| 09/09/2009 | CN100537542C Farnesyl protein transferase inhibitors as antitumor agents |
| 09/09/2009 | CN100537527C Aryl and biaryl compounds having MCH modulatory activity |
| 09/09/2009 | CN100536914C Anti-oxidation, anti-senium oyster product and its preparation method |
| 09/09/2009 | CN100536912C Use of HCG in controlled ovarian hyperstimulation |
| 09/09/2009 | CN100536911C Peptide composition |
| 09/09/2009 | CN100536858C Substances extracted from dictyotales, Preparation method therefor, and compositions containing same |
| 09/09/2009 | CN100536856C Use of bioactive composition derived from cattle urine distillate ('Go-mutra') as anti-infective,anti-tumour and biological intensifier of nutriment |
| 09/09/2009 | CN100536846C Compositions comprising HMG-CoA reductase inhibitor |
| 09/09/2009 | CN100536844C Pharmaceutical paste comprising acid-labile activeingredient |
| 09/09/2009 | CN100536839C Urea derivatives as integrin alpha 4 antagonists |
| 09/09/2009 | CN100536833C Improved pharmaceutical formulations |
| 09/08/2009 | US7585889 cloprostenol or latanoprost; topical use; highly crystalline structures that are easy to formulate into ophthalmic solutions; hydrolysis of these analogs does not have toxic and irritant small aliphatic alcohol coproducts; hypotensive agent for intraocular pressure |
| 09/08/2009 | US7585880 Phenylpropanoic acid derivatives |
| 09/08/2009 | US7585863 Antitumor agents; such as (2-(4-(7-Chloro-2-quinoxalinyl)oxy)propionylamino ethansulfonic acid; {2-{4-(7-Chloro-quinoxalin-2-yloxy)-phenoxy}propionyl amino}acetic acid |
| 09/08/2009 | US7585860 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/08/2009 | US7585857 Cytotoxic agents comprising taxanes and their therapeutic use |
| 09/08/2009 | US7585841 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src |
| 09/08/2009 | US7585834 Transport moiety comprises a structure; (ZYZ)nZ, (ZY)nZ, (ZYY)nZ or (ZYYY)nZ, wherein each Z is L-arginine or D-arginine, and each Y is independently an amino acid that does not comprise an amidino or guanidino moiety; n=2-10 |
| 09/08/2009 | US7585673 secreted by human breast cancer MDA-MB-175 cells, leads to the formation of a constitutive active receptor complex and stimulates the growth of these cells in an autocrine manner |
| 09/08/2009 | US7585671 Hedgehog interacting proteins and uses related thereto |
| 09/08/2009 | US7585666 genetically engineered chimeras comprising ligand binding domain fused to an effector domain of an apoptosis signaling molecule and second encoding a cis acting regulatory element; for use in/ex vivo |
| 09/08/2009 | US7585622 Increasing the proliferative capacity of cells using telomerase reverse transcriptase |
| 09/08/2009 | US7585520 Compositions containing both sedative and non-sedative antihistamines and sleep aids |
| 09/08/2009 | US7585507 Nucleic acid molecules and polypeptides for immune modulation |
| 09/08/2009 | US7585502 Antigen binding fragment binds to denatured polypeptide which chemoattracts peripheral blood monocytes or T-cells; immunization |
| 09/08/2009 | US7585497 Comprises nucleotide sequences coding insulin-like growth factor binding protein-3 and receptors for diagnosis, prevention and treatment of cancer; antitumor/anticarcinogenic agents |
| 09/08/2009 | CA2519919C Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 09/08/2009 | CA2463598C Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists |
| 09/08/2009 | CA2440931C Hiv protease inhibitors based on amino acid derivatives |
| 09/08/2009 | CA2417758C Use of the combination of nicotinic acid or derivatives with riboflavin in the manufacture of a medicament for the treatment of primary headaches |
| 09/08/2009 | CA2409546C Peptides and derivatives thereof showing cell attachment, spreading and detachment activity |
| 09/08/2009 | CA2387351C Indole derivatives as tyrosine kinase inhibitors |
| 09/08/2009 | CA2360360C Piperidyl benzamide compounds, composition containing same and their use thereof |
| 09/08/2009 | CA2353865C Therapeutic agents for hyperammonemia |
| 09/08/2009 | CA2341010C Process for the manufacture of ethanesulfonyl-piperidine derivatives |
| 09/08/2009 | CA2335623C Aminoiminoquinone and aminoquinine alkaloid compounds as capase inhibitors |
| 09/08/2009 | CA2293714C Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase |
| 09/08/2009 | CA2284750C Steroid sulfamates, method for the production and use thereof |
| 09/08/2009 | CA2213466C Inhibitors of microsomal triglyceride transfer protein and method |
| 09/03/2009 | WO2009108760A2 Dendritic macroporous hydrogels prepared by crystal templating |
| 09/03/2009 | WO2009107767A1 Novel bicyclic pyrimidine derivative having antagonistic activity on h4 receptor |
| 09/03/2009 | WO2009107766A1 Pharmaceutical composition for transnasal administration |
| 09/03/2009 | WO2009107762A1 Aromatic amide derivative |
| 09/03/2009 | WO2009107736A1 Fibrosis inhibitor |
| 09/03/2009 | WO2009107660A1 Prophylactic or therapeutic agent for diabetes or obesity |
| 09/03/2009 | WO2009107391A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | WO2009107389A1 Tricyclic compound |
| 09/03/2009 | WO2009107322A1 Pharmaceutical composition for treatment of cancer |
| 09/03/2009 | WO2009106597A1 Use of lhrh antagonists at non-castrating doses |
| 09/03/2009 | WO2009105936A1 The use of phenolic glycosides derivatives in the manufacture of compositions for treating cell proliferation diseases |
| 09/03/2009 | WO2009105912A1 A fat emulsion containing ganoderma spore oil, its quality control methods and its use |
| 09/03/2009 | WO2009073683A3 Methods of treating copd |
| 09/03/2009 | WO2009061447A9 Treatment of premature birth complications |
| 09/03/2009 | US20090221699 Fab I Inhibitors |
| 09/03/2009 | US20090221691 Compositions and methods for inhibiting g protein signaling |
| 09/03/2009 | US20090221684 Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof |
| 09/03/2009 | US20090221632 Bicyclo-Pyrazoles and Pharmaceutical Compositions Comprising Them |
| 09/03/2009 | US20090221602 Processes for preparing substituted pyrimidines |
| 09/03/2009 | US20090221601 Methods of identifying and treating individuals exhibiting mutant kit protein |
| 09/03/2009 | US20090221519 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 09/03/2009 | US20090221504 Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| 09/03/2009 | US20090221492 Expression of active human factor ix in mammary tissue of transgenic animals |
| 09/03/2009 | US20090221489 Water-Soluable Films Comprising Low-Viscosity Alginates |
| 09/03/2009 | US20090220603 Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics |
| 09/03/2009 | US20090220587 Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands |
| 09/03/2009 | US20090220505 Methods of inhibiting amyloid toxicity |
| 09/03/2009 | US20090220480 Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |
| 09/03/2009 | US20090220460 Virus strains |
| 09/03/2009 | US20090220431 Magnetic resonance imaging contrast agents containing water-soluble nanoparticles of manganese oxide or manganese metal oxide |
| 09/03/2009 | US20090220426 Biodegradable Inverted-Opal Structure, Method for Manufacturing and Using the Same, and Medical Implant Comprising the Biodegradable Inverted-Opal Structure |
| 09/03/2009 | US20090220421 Method for screening mtp-inhibiting compounds |
| 09/03/2009 | CA2716898A1 Compound having 6-membered aromatic ring |
| 09/03/2009 | CA2716572A1 Use of lhrh antagonists at non-castrating doses |
| 09/03/2009 | CA2716565A1 Pharmaceutical composition for transnasal administration |
| 09/02/2009 | EP2096167A1 Aptamer against midkine and use thereof |
| 09/02/2009 | EP2096112A2 Thiazoline acid derivatives |
| 09/02/2009 | EP2096111A1 Pyrazoles and use thereof as drugs |
| 09/02/2009 | EP2096109A1 Carboxylic acid derivative |
| 09/02/2009 | EP2096106A1 Novel polyamine derivatives |